GlaxoSmithKline Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.21%138.070.7%$845.74m
PFEPfizer Inc. -0.06%35.430.9%$818.09m
MRKMerck & Co., Inc. 0.03%76.200.7%$636.42m
ABBVAbbVie, Inc. 0.78%81.121.9%$581.21m
BMYBristol-Myers Squibb Co. 0.68%58.161.0%$577.30m
LLYEli Lilly & Co. 1.17%132.851.1%$523.40m
AZNAstraZeneca Plc 0.61%51.291.2%$213.63m
GSKGlaxoSmithKline Plc 0.32%34.060.2%$154.52m
NVSNovartis AG -0.07%78.310.2%$143.36m
NVONovo Nordisk A/S 0.08%66.610.1%$69.86m
RGENRepligen Corp. 1.05%173.007.1%$65.51m
RPRXRoyalty Pharma Plc 0.91%36.450.2%$62.64m
TPTXTurning Point Therapeutics, Inc. -2.69%101.620.0%$58.53m
SNYSanofi -1.07%45.650.2%$49.07m
AMAGAMAG Pharmaceuticals, Inc. -0.04%13.7122.1%$47.79m

Company Profile

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.